Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NOTCH2NLR, more accurately related to the human-specific NOTCH2NL gene family (including NOTCH2NLA, NOTCH2NLB, and NOTCH2NLC), encodes proteins structurally similar to the N-terminal, EGF-like repeat-rich domain of the NOTCH2 receptor. These proteins are expressed in neural progenitor regions of the developing human cortex and can physically interact with NOTCH2 and other NOTCH receptors, enhancing Notch pathway signaling and promoting maintenance and proliferation of neuronal progenitors, thus delaying their differentiation[2][3]. The "R" designation or "Notch 2 N-terminal like R" is uncommon in major gene/protein databases and likely represents a recently identified paralog, truncated variant, or potentially a pseudogene entry. While NOTCH2NL genes broadly have evolutionary and developmental significance, NOTCH2NLR itself is not recognized as a therapeutic target, and no known drugs or clinical biomarkers are associated with it[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch homolog 2 N-terminal-like protein R (NOTCH2NLR).